-
1 Comment
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd is currently in a long term uptrend where the price is trading 12.6% above its 200 day moving average.
From a valuation standpoint, the stock is 27.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.0.
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd's total revenue sank by 26.8% to $103M since the same quarter in the previous year.
Its net income has dropped by 200.3% to $-13M since the same quarter in the previous year.
Finally, its free cash flow grew by 449.0% to $27M since the same quarter in the previous year.
Based on the above factors, Zhejiang Shapuaisi Pharmaceutical Co.,Ltd gets an overall score of 3/5.
| Sector | Healthcare |
|---|---|
| Industry | Drug Manufacturers - Specialty & Generic |
| Exchange | SHG |
| CurrencyCode | CNY |
| ISIN | CNE100001TG0 |
| Beta | 0.39 |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Market Cap | 3B |
| Dividend Yield | None |
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antimicrobials, gynecology, and other classes. It offers its products in injections, oral solutions, eye drops, tablets, capsules, and other dosage forms. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was founded in 1978 and is based in Pinghu, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 603168.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
